Relationship between Serum Irisin Level, All-Cause Mortality, and Cardiovascular Mortality in Peritoneal Dialysis Patients
Kidney and Blood Pressure Research · 2024
DOI: 10.1159/000535582 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Kidney and Blood Pressure Research, 2024. Verfasst von Sijia Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Peritoneal Dialysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
This study aimed to investigate the prospective role of serum irisin – a novel adipo-myokine – in all-cause mortality and cardiovascular (CV) mortality in patients on peritoneal dialysis (PD).
Methods
A prospectively observational study was conducted with 154 PD patients. Baseline clinical data were collected from the medical records. Serum irisin concentrations were determined using enzyme-linked immunosorbent assay. Patients were divided into the high irisin group (serum irisin ≥113.5 ng/mL) and the low irisin group (serum irisin <113.5 ng/mL) based on the median value of serum irisin. A body composition monitor was used to monitor body composition. Cox regression analysis was utilized to find the independent risk factors of all-cause and CV mortality in PD patients.
Results
The median serum irisin concentration was 113.5 ng/mL (interquartile range, 106.2–119.8 ng/mL). Patients in the high irisin group had significantly higher muscle mass and carbon dioxide combining power (CO2CP) than those in the low irisin group (p < 0.05). Serum irisin was positively correlated with pulse pressure, CO2CP, and muscle mass, while negatively correlated with body fat percentage (p < 0.05). During a median of follow-up for 60.0 months, there were 55 all-cause deaths and 26 CV deaths. Patients in the high irisin group demonstrated a higher CV survival rate than those in the low irisin group (p = 0.016). Multivariate Cox regression analysis showed that high irisin level (hazard ratio [HR], 0.341; 95% confidence interval [CI], 0.135–0.858; p = 0.022), age, and diabetic mellitus were independently associated with CV mortality in PD patients. However, serum irisin level failed to demonstrate a statistically significant relationship with all-cause mortality.
Conclusion
Low serum irisin levels at baseline were independently predictive of CV mortality but not all-cause mortality in PD patients. Therefore, serum irisin could be a potential target for monitoring CV outcomes in PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Peking University Third Hospital, Beijing, China.
- Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
- Department of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, China.
Zitieren
APA
Zhou, S., Tang, W., Wang, X., Han, Q., Bai, Q., & Zhang, A. (2024). Relationship between Serum Irisin Level, All-Cause Mortality, and Cardiovascular Mortality in Peritoneal Dialysis Patients. Kidney and Blood Pressure Research. https://doi.org/10.1159/000535582
Vancouver
Zhou S, Tang W, Wang X, Han Q, Bai Q, Zhang A. Relationship between Serum Irisin Level, All-Cause Mortality, and Cardiovascular Mortality in Peritoneal Dialysis Patients. Kidney and Blood Pressure Research. 2024. doi:10.1159/000535582
BibTeX
@article{Zhou2024,
author = {Zhou, Sijia and Tang, Wen and Wang, Xiaoxiao and Han, Qingfeng and Bai, Qiong and Zhang, Aihua},
title = {Relationship between Serum Irisin Level, All-Cause Mortality, and Cardiovascular Mortality in Peritoneal Dialysis Patients},
journal = {Kidney and Blood Pressure Research},
year = {2024},
doi = {10.1159/000535582}
}
EUVIMED